Characterization of serological responses to pertussis

Clinical and Vaccine Immunology

Volumn 13, Issue 3, 2006, Pages 341-348

  Watanabe, Mineo ^a,c   Connelly, Beverly ^b   Weiss, Alison A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c KITASATO INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE TOXIN; BACTERIAL ANTIGEN; HEMAGGLUTININ; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; LIPOOLIGOSACCHARIDE; LIPOPROTEIN; PEPTIDOGLYCAN; PEPTIDOGLYCAN ASSOCIATED LIPOPROTEIN; PERTUSSIS TOXIN; PERTUSSIS VACCINE; PROTEIN BRKA; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTERIUM CULTURE; BORDETELLA PERTUSSIS; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; PERTUSSIS; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SERODIAGNOSIS; SERUM;

ADULT; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BORDETELLA PARAPERTUSSIS; BORDETELLA PERTUSSIS; CHILD; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LIPOPOLYSACCHARIDES; PERTUSSIS VACCINE; SENSITIVITY AND SPECIFICITY; TIME FACTORS; WHOOPING COUGH;

EID: 33645540515     PISSN: 15566811     EISSN: None     Source Type: Journal    
DOI: 10.1128/CVI.13.3.341-348.2006     Document Type: Article

References (36)

1. Arciniega, J. L., E. L. Hewlett, K. M. Edwards, and D. L. Burns. 1993. Antibodies to Bordetella pertussis adenylate cyclase toxin in neonatal and maternal sera. FEMS Immunol. Med. Microbiol. 6:325-330.
2. Barenkamp, S. J., and E. Leininger. 1992. Cloning, expression, and DNA sequence analysis of genes encoding nontypeable Haemophilus influenzae high-molecular-weight surface-exposed proteins related to filamentous hemagglutinin of Bordetella pertussis. Infect. Immun. 60:1302-1313.
3. Bauer, M. E., and R. A. Welch. 1996. Characterization of an RTX toxin from enterohemorrhagic Escherichia coli O157:H7. Infect. Immun. 64:167-175.
4. Baughman, A. L., K. M. Bisgard, K. M. Edwards, D. Guris, M. D. Decker, K. Holland, B. D. Meade, and F. Lynn. 2004. Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States. Clin. Diagn. Lab. Immunol. 11:1045-1053.
5. Carbonetti, N. H., G. V. Artamonova, C. Andreasen, E. Dudley, R. M. Mays, and Z. E. Worthington. 2004. Suppression of serum antibody responses by pertussis toxin after respiratory tract colonization by Bordetella pertussis and identification of an immunodominant lipoprotein. Infect. Immun. 72:3350-3358.
6. Caroff, M., L. Aussel, H. Zarrouk, A. Martin, J. C. Richards, H. Therisod, M. B. Perry, and D. Karihian. 2001. Structural variability and originality of the Bordetella endotoxins. J. Endotoxin Res. 7:63-68.
7. Cascales, E., and R. Lloubes. 2004. Deletion analyses of the peptidoglycan-associated lipoprotein Pal reveals three independent binding sequences including a TolA box. Mol. Microbiol. 51:873-885.
8. Centers for Disease Control and Prevention. January 2005, revised date. Guideline for the control of pertussis outbreak. [Online.] http://www.cdc.gov /nip/publications/pertussis/guide.htm. Accessed 28 September 2005.
9. Centers for Disease Control and Prevention. January 2005, revised date. The Pink Book, updated 8th ed., 2nd printing. [Online.] http://www.cdc.gov/nip /publications/pink/pert.pdf. Accessed 28 September 2005.
10. Chart, H., S. M. Scotland, and B. Rowe. 1989. Serum antibodies to Escherichia coli serotype O157:H7 in patients with hemolytic-uremic syndrome. J. Clin. Microbiol. 27:285-290.
11. Cherry, J. D., D. X. Xing, P. Newland, K. Patel, U. Heininger, and M. J. Corbel. 2004. Determination of serum antibody to Bordetella pertussis adenylate cyclase toxin in vaccinated and unvaccinated children and in children and adults with pertussis. Clin. Infect. Dis. 38:502-507.
12. Chong, P., and M. Klein. 1989. Single-step purification of pertussis toxin and its subunits by heat-treated fetuin-Sepharose affinity chromatography. Biochem. Cell Biol. 67:387-391.
13. Coutte, L., S. Alonso, N. Reveneau, E. Willery, B. Quatannens, C. Locht, and F. Jacob-Dubuisson. 2003. Role of adhesin release for mucosal colonization by a bacterial pathogen. J. Exp. Med. 197:735-742.
14. Coutte, L., R. Antoine, H. Drobecq, C. Locht, and F. Jacob-Dubuisson. 2001. Subtilisin-like autotransporter serves as maturation protease in a bacterial secretion pathway. EMBO J. 20:5040-5048.
15. Crowcroft, N. S., and J. Britto. 2002. Whooping cough-a continuing problem. BMJ 324:1537-1538.
16. Reference deleted.
17. Ehrmann, I. E., M. C. Gray, V. M. Gordon, L. S. Gray, and E. L. Hewlett. 1991. Hemolytic activity of adenylate cyclase toxin from Bordetella pertussis. FEBS Lett. 278:79-83.
18. Fernandez, R. C., and A. A. Weiss. 1994. Cloning and sequencing of a Bordetella pertussis serum resistance locus. Infect. Immun. 62:4727-4738.
19. Forsyth, K. D., M. Campins-Marti, J. Caro, J. D. Cherry, D. Greenberg, N. Guiso, U. Heininger, J. Schellekens, T. Tan, C. H. von Konig, and S. Plotkin. 2004. New pertussis vaccination strategies beyond infancy: recommendations by the global pertussis initiative. Clin. Infect. Dis. 39:1802-1809.
20. Greiner, M., D. Pfeiffer, and R. D. Smith. 2000. Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. Prev. Vet. Med. 45:23-41.
21. Hewlett, E. L., and K. M. Edwards. 2005. Clinical practice. Pertussis-not just for kids. N. Engl. J. Med. 352:1215-1222.
22. Lee, S. J., M. C. Gray, L. Guo, P. Seho, and E. L. Hewlett. 1999. Epitope mapping of monoclonal antibodies against Bordetella pertussis adenylate cyclase toxin. Infect. Immun. 67:2090-2095.
23. Manclark, C. R., B. D. Meade, and D. G. Burstyn. 1986. Serological response to Bordetella pertussis, p. 388-394. In N. R. Rose, H. Friedman, and J. L. Fahey (ed.), Manual of clinical immunology. American Society for Microbiology. Washington, D.C.
24. Menozzi, F. D., C. Gantiez, and C. Locht. 1991. Interaction of the Bordetella pertussis filamentous hemagglutinin with heparin. FEMS Microbiol. Lett. 62:59-64.
25. Mobberley-Schuman, P. S., B. Connelly, and A. A. Weiss. 2003. Phagocytosis of Bordetella pertussis incubated with convalescent serum. J. Infect. Dis. 187:1646-1653.
26. Oliver, D. C., and R. C. Fernandez. 2001. Antibodies to BrkA augment killing of Bordetella pertussis. Vaccine 20:235-241.
27. Preston, A., D. Maskell, A. Johnson, and E. R. Moxon. 1996. Altered lipopolysaccharide characteristic of the 169 phenotype in Haemophilus influenzae results from mutations in a novel gene, isn. J. Bacteriol. 178:396-402.
28. Renauld-Mongenie, G., J. Cornette, N. Mielcarek, F. D. Menozzi, and C. Locht. 1996. Distinct roles of the N-terminal and C-terminal precursor domains in the biogenesis of the Bordetella pertussis filamentous hemagglutinin. J. Bacteriol. 178:1053-1060.
29. Sambrook, J., and D. Russell. 2001. Molecular cloning, vol. 3, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
30. Sekura, R. D., F. Fish, C. R. Manclark, B. Meade, and Y. L. Zhang. 1983. Pertussis toxin. Affinity purification of a new ADP-ribosyltransferase. J. Biol. Chem. 258:14647-14651.
31. Senzilet, L. D., S. A. Halperin, J. S. Spika, M. Alagaratnam, A. Morris, and B. Smith. 2001. Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin. Infect. Dis. 32:1691-1697.
32. Strebel, P., J. Nordin, K. Edwards, J. Hunt, J. Besser, S. Burns, G. Amundson, A. Baughman, and W. Wattigney. 2001. Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996. J. Infect. Dis. 183:1353-1359.
33. Tozzi, A. E., L. P. Celentano, M. L. Ciofi degli Atti, and S. Salmaso. 2005. Diagnosis and management of pertussis. Can. Med. Assoc. J. 172:509-515.
34. Watanabe, M., and M. Nagai. 2004. Whooping cough due to Bordetella parapertussis: an unresolved problem. Expert. Rev. Anti. Infect. Ther. 2:447-454.
35. Weingart, C. L., and A. A. Weiss. 2000. Bordetella pertussis virulence factors affect phagocytosis by human neutrophils. Infect. Immun. 68:1735-1739.
36. World Health Organization. 2001, posting date. Pertussis surveillance. [Online.] http://www.who.int/vaccines-documents/DocsPDF01/www.605.pdf. Accessed 28 September 2005.